8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
BECTON DICKINSON & CO (BDX)

BD executive Michael Garrison to retire after fiscal year-end

Filed with the SEC on · Summarized by InvestorsBot

On July 19, 2026, Michael D. Garrison informed Becton, Dickinson and Company that he intends to retire and will remain executive vice president and president of the Medical Essentials and BioPharma Systems segments through the end of the fiscal year to support the transition. BD is searching for a new Medical Essentials president, while the BioPharma Systems segment will report directly to Chairman, CEO and President Thomas E. Polen as part of a streamlined operating model.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from BECTON DICKINSON & CO

Becton Dickinson Furnishes July 22 Press Release in SEC Filing

8-K · July 22, 2026

BD Issues Press Release on Item 5.02 Matters

8-K · July 22, 2026

Becton Dickinson filed an 8-K on Feb 25, 2026 disclosing press releases (Ex.99.1 & 99.2) on early tender…

8-K · February 25, 2026

Becton Dickinson ($BDX) upsizes tender offers to repurchase up to $2.00B of senior notes; Company…

8-K · February 25, 2026

Becton Dickinson filed an 8‑K dated Feb 10, 2026.

8-K · February 10, 2026

Feb 10, 2026: Becton, Dickinson & Co.

8-K · February 10, 2026